Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in NERV — Minerva Neurosciences, Inc.

CIK 19617 NEW YORK, NY
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$78,338
+$78,310 QoQ
Shares Held
14,115
+82929.4% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 58 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. NERV ranks #281 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in NERV

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $78,338 14,115
2025-03-31 $28 17
2024-12-31 $37 17
2023-09-30 $62 9
2023-06-30 $41,284 4,517
2023-03-31 $4 3
2022-12-31 $4 3
2022-09-30 $27 3
2022-06-30 $9 3
2022-03-31 $537 647
2021-09-30 $30,093 17,295
2021-06-30 $275,059 118,560
2021-03-31 $540,699 185,171
2020-12-31 $427,907 182,867
2020-09-30 $378,387 118,990
2020-06-30 $470,292 130,275
2020-03-31 $622,618 103,425